Pharmacyclics Reports First Quarter 2013 Results
May 01, 2013
from PR Newswire
Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
April 24, 2013
from PR Newswire
from PR Newswire
Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope
April 16, 2013
from PR Newswire
Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
April 11, 2013
from PR Newswire
from PR Newswire
Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
April 08, 2013
from PR Newswire
Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope
March 13, 2013
from PR Newswire
Pharmacyclics, Inc. Prices Public Offering of Common Stock
March 08, 2013
from PR Newswire
from PR Newswire
Critical Alerts For Qualcomm, CBS, DaVita, O'Reilly Automotive, and Pharmacyclics Released By InvestorsObserver
March 07, 2013
from PR Newswire
from PR Newswire
Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
February 12, 2013
from PR Newswire
Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
February 07, 2013
from PR Newswire
Should Recent Insider Selling on TOL, CVH, SWI and PCYC Matter to You?
December 20, 2012
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Hematology (ASH) Annual Meeting
December 11, 2012
Investigational agent ibrutinib (PCI-32765) demonstrates prolonged progression free survival with a manageable and predictable safety profile in high unmet need indications; relapsed and refractory,... Read More
from PR Newswire
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
December 11, 2012
from PR Newswire
Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
December 08, 2012
from PR Newswire
Critical Alerts For Amazon.com, Estee Lauder, Kroger, Pharmacyclics, and Zillow Released By InvestorsObserver
December 04, 2012
from PR Newswire
Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
November 05, 2012
from PR Newswire
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III Chronic Lymphocytic Leukemia Combination Trial
October 15, 2012
from PR Newswire
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
September 05, 2012
from PR Newswire
Pharmacyclics® Triggers Significant Milestone Payment For Mantle Cell Lymphoma Clinical Trial
August 20, 2012
from PR Newswire
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here